Ligand id: 7116

Name: antazoline

Structure and Physico-chemical Properties

2D Structure
Calculated Physico-chemical Properties
Hydrogen bond acceptors 3
Hydrogen bond donors 1
Rotatable bonds 5
Topological polar surface area 27.63
Molecular weight 265.16
XLogP 4.95
No. Lipinski's rules broken 0

Molecular properties generated using the CDK

No information available.
Summary of Clinical Use
There is no information regarding approval for clinical use of this drug on the US FDA website. Other national approval agencies may have granted marketing authorisation.
Antazoline is contained in brand mixture eye drops, in combination with xylometazoline (Otrivine antistin®) or naphazoline (Vasocon-A®) used for temporary relief of allergic conjunctivitis.
Mechanism Of Action and Pharmacodynamic Effects
Antazoline blocks the action of endogenous histamine at the histamine H1 receptor.
External links